Work

The FDA Critical Path Initiative and Its Influence on New Drug Development

Year: 2008

Type: article

Source: Annual Review of Medicine

DOI: 10.1146/annurev.med.59.090506.155819

Authors: Janet Woodcock, Raymond Woosley

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Critical Path Institute

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2143548516

FWCI: 59.58

Cites: 11

Cited by: 441

Related to: 9